Index by author

01 April 2011; volume 37, issue 4

A

  1. Adcock, I.M.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  2. Agostoni, P.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  3. Akram, A.R.

    1. Chalmers, J.D., A.R. Akram, and A.T. Hill. "Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis." European Respiratory Journal 37.4 (2011): 858-864. Web. 19 Jan. 2022.

  4. Álvarez, L.

    1. Sáenz, A. et al "Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation." European Respiratory Journal 37.4 (2011): 925-932. Web. 19 Jan. 2022.

  5. Amin, R.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

  6. Aujesky, D.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

B

  1. Bækvad-Hansen, M.

    1. Bækvad-Hansen, M., B.G. Nordestgaard, and M. Dahl. "Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals." European Respiratory Journal 37.4 (2011): 791-799. Web. 19 Jan. 2022.

  2. Balkovec, S.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

  3. Banfi, C.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  4. Barberà, J.A.

    1. Barberà, J.A., and V.I. Peinado. "Disruption of the lung structure maintenance programme: a comprehensive view of emphysema development." European Respiratory Journal 37.4 (2011): 752-754. Web. 19 Jan. 2022.

  5. Bendstrup, E.

    1. Hyldgaard, C. et al "An unusual presentation of sarcoidosis with tetraplegia and severe osteolytic bone lesions." European Respiratory Journal 37.4 (2011): 964-966. Web. 19 Jan. 2022.

  6. Berna, G.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  7. Bernaudin, J-F.

    1. Kambouchner, M. et al "Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas." European Respiratory Journal 37.4 (2011): 835-840. Web. 19 Jan. 2022.

  8. Bhavsar, P.K.

    1. Li, F. et al "Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids." European Respiratory Journal 37.4 (2011): 933-942. Web. 19 Jan. 2022.

  9. Boerrigter, B.G.

    1. Boerrigter, B.G. et al "Cardiac shunt in COPD as a cause of severe hypoxaemia: probably not so uncommon after all." European Respiratory Journal 37.4 (2011): 960-962. Web. 19 Jan. 2022.

  10. Bogaard, H.J.

    1. Yasuo, M. et al "Hypoxia inducible factor-1α in human emphysema lung tissue." European Respiratory Journal 37.4 (2011): 775-783. Web. 19 Jan. 2022.

  11. Bohács, A.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

  12. Boonstra, A.

    1. Boerrigter, B.G. et al "Cardiac shunt in COPD as a cause of severe hypoxaemia: probably not so uncommon after all." European Respiratory Journal 37.4 (2011): 960-962. Web. 19 Jan. 2022.

  13. Brambillasca, C.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  14. Brioschi, M.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  15. Brockmann, P.E.

    1. Urschitz, M.S. et al "From the authors:." European Respiratory Journal 37.4 (2011): 975-976. Web. 19 Jan. 2022.

  16. Brugniaux, J.V.

    1. Brugniaux, J.V. et al "Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans." European Respiratory Journal 37.4 (2011): 880-887. Web. 19 Jan. 2022.

  17. Bush, A.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

C

  1. Cardini, S.

    1. De Cunto, G. et al "Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2." European Respiratory Journal 37.4 (2011): 823-834. Web. 19 Jan. 2022.

  2. Carlsen, K-H.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

  3. Casals, C.

    1. Sáenz, A. et al "Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation." European Respiratory Journal 37.4 (2011): 925-932. Web. 19 Jan. 2022.

  4. Castillo-Olivares, J.L.

    1. Sáenz, A. et al "Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation." European Respiratory Journal 37.4 (2011): 925-932. Web. 19 Jan. 2022.

  5. Chalmers, J.D.

    1. Chalmers, J.D., A.R. Akram, and A.T. Hill. "Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis." European Respiratory Journal 37.4 (2011): 858-864. Web. 19 Jan. 2022.

  6. Chandra, D.

    1. Puhan, M.A. et al "The minimal important difference of exercise tests in severe COPD." European Respiratory Journal 37.4 (2011): 784-790. Web. 19 Jan. 2022.

  7. Chaumais, M-C.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  8. Chung, K.F.

    1. Li, F. et al "Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids." European Respiratory Journal 37.4 (2011): 933-942. Web. 19 Jan. 2022.

  9. Cirino, G.

    1. De Cunto, G. et al "Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2." European Respiratory Journal 37.4 (2011): 823-834. Web. 19 Jan. 2022.

  10. Clancy, L.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

  11. Clark, A.R.

    1. Li, F. et al "Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids." European Respiratory Journal 37.4 (2011): 933-942. Web. 19 Jan. 2022.

  12. Clelland, C.A.

    1. Slade, M.G. et al "Improving standards in flexible bronchoscopy for lung cancer." European Respiratory Journal 37.4 (2011): 895-901. Web. 19 Jan. 2022.

  13. Cool, C.D.

    1. Yasuo, M. et al "Hypoxia inducible factor-1α in human emphysema lung tissue." European Respiratory Journal 37.4 (2011): 775-783. Web. 19 Jan. 2022.

  14. Corral, J.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  15. Curry, L.

    1. Slade, M.G. et al "Improving standards in flexible bronchoscopy for lung cancer." European Respiratory Journal 37.4 (2011): 895-901. Web. 19 Jan. 2022.

D

  1. Dahl, M.

    1. Bækvad-Hansen, M., B.G. Nordestgaard, and M. Dahl. "Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals." European Respiratory Journal 37.4 (2011): 791-799. Web. 19 Jan. 2022.

  2. Dakin, C.

    1. Pham, T.M.T. et al "Regional ventilation distribution in the first 6 months of life." European Respiratory Journal 37.4 (2011): 919-924. Web. 19 Jan. 2022.

  3. Dalphin, J.C.

    1. Thaon, I. et al "Influence of hay and animal feed exposure on respiratory status: a longitudinal study." European Respiratory Journal 37.4 (2011): 767-774. Web. 19 Jan. 2022.

  4. Dara, M.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

  5. Decramer, M.

    1. Decramer, M., C. Roussos, and J. Hogg. "In memoriam Prof. Peter T. Macklem, 1931–2011: a tribute from the European Respiratory Society." European Respiratory Journal 37.4 (2011): 735-737. Web. 19 Jan. 2022.
    2. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

  6. De Cunto, G.

    1. De Cunto, G. et al "Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2." European Respiratory Journal 37.4 (2011): 823-834. Web. 19 Jan. 2022.

  7. Denning, D.W.

    1. Smith, N.L., and D.W. Denning. "Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma." European Respiratory Journal 37.4 (2011): 865-872. Web. 19 Jan. 2022.

  8. Dorfmüller, P.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  9. Duffek, L.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

  10. Duggan, C.T.C.

    1. Brugniaux, J.V. et al "Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans." European Respiratory Journal 37.4 (2011): 880-887. Web. 19 Jan. 2022.

E

  1. Eliasziw, M.

    1. Brugniaux, J.V. et al "Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans." European Respiratory Journal 37.4 (2011): 880-887. Web. 19 Jan. 2022.

  2. Ewert, R.

    1. Wensel, R. et al "Prognosis in pulmonary arterial hypertension." European Respiratory Journal 37.4 (2011): 971-972. Web. 19 Jan. 2022.

F

  1. Falzon, D.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

  2. Farré, R.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  3. Fernandez-Marin, M.C.

    1. Jurado-Gámez, B. et al "Relationship of oxidative stress and endothelial dysfunction in sleep apnoea." European Respiratory Journal 37.4 (2011): 873-879. Web. 19 Jan. 2022.

  4. Finn, D.

    1. Finn, D., and P. McNally. "Estimated population prevalence of obstructive sleep apnoea in a community of German third graders." European Respiratory Journal 37.4 (2011): 975. Web. 19 Jan. 2022.

  5. Foster, G.E.

    1. Brugniaux, J.V. et al "Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans." European Respiratory Journal 37.4 (2011): 880-887. Web. 19 Jan. 2022.

G

  1. Gambaryan, N.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  2. Geppetti, P.

    1. De Cunto, G. et al "Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2." European Respiratory Journal 37.4 (2011): 823-834. Web. 19 Jan. 2022.

  3. Gielis, J.

    1. Gielis, J. et al "Nodular pulmonary ossifications in differential diagnosis of solitary pulmonary nodules." European Respiratory Journal 37.4 (2011): 966-968. Web. 19 Jan. 2022.

  4. Gläser, S.

    1. Wensel, R. et al "Prognosis in pulmonary arterial hypertension." European Respiratory Journal 37.4 (2011): 971-972. Web. 19 Jan. 2022.

  5. Gleeson, F.V.

    1. Slade, M.G. et al "Improving standards in flexible bronchoscopy for lung cancer." European Respiratory Journal 37.4 (2011): 895-901. Web. 19 Jan. 2022.

  6. Gómez, V.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

  7. Gómez-Chaparro, J.L.

    1. Jurado-Gámez, B. et al "Relationship of oxidative stress and endothelial dysfunction in sleep apnoea." European Respiratory Journal 37.4 (2011): 873-879. Web. 19 Jan. 2022.

  8. González, M.T.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  9. Guenther, A.

    1. Guenther, A.. "The European IPF Network: towards better care for a dreadful disease." European Respiratory Journal 37.4 (2011): 747-748. Web. 19 Jan. 2022.

  10. Gustafsson, P.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

H

  1. Hall, G.L.

    1. Hall, G.L., and J. Stocks. "Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash?." European Respiratory Journal 37.4 (2011): 757-759. Web. 19 Jan. 2022.

  2. Hanly, P.J.

    1. Brugniaux, J.V. et al "Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans." European Respiratory Journal 37.4 (2011): 880-887. Web. 19 Jan. 2022.

  3. Hansel, N.N.

    1. Puhan, M.A. et al "The minimal important difference of exercise tests in severe COPD." European Respiratory Journal 37.4 (2011): 784-790. Web. 19 Jan. 2022.

  4. Hari, D.T.

    1. Mohapatra, P.R., and D.T. Hari. "Predicting outcomes and drug resistance with new standardised treatment." European Respiratory Journal 37.4 (2011): 974. Web. 19 Jan. 2022.

  5. Hilberg, O.

    1. Hyldgaard, C. et al "An unusual presentation of sarcoidosis with tetraplegia and severe osteolytic bone lesions." European Respiratory Journal 37.4 (2011): 964-966. Web. 19 Jan. 2022.

  6. Hill, A.T.

    1. Chalmers, J.D., A.R. Akram, and A.T. Hill. "Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis." European Respiratory Journal 37.4 (2011): 858-864. Web. 19 Jan. 2022.

  7. Hjorthaug, K.

    1. Hyldgaard, C. et al "An unusual presentation of sarcoidosis with tetraplegia and severe osteolytic bone lesions." European Respiratory Journal 37.4 (2011): 964-966. Web. 19 Jan. 2022.

  8. Hogg, J.

    1. Decramer, M., C. Roussos, and J. Hogg. "In memoriam Prof. Peter T. Macklem, 1931–2011: a tribute from the European Respiratory Society." European Respiratory Journal 37.4 (2011): 735-737. Web. 19 Jan. 2022.

  9. Hoogendijk, A.J.

    1. Wieland, C.W. et al "Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2." European Respiratory Journal 37.4 (2011): 848-857. Web. 19 Jan. 2022.

  10. Horváth, I.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

  11. Howard, L.S.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  12. Humbert, M.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.
    2. Humbert, M. et al "From the authors:." European Respiratory Journal 37.4 (2011): 972-973. Web. 19 Jan. 2022.

  13. Hussain, F.

    1. Li, F. et al "Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids." European Respiratory Journal 37.4 (2011): 933-942. Web. 19 Jan. 2022.

  14. Hyldgaard, C.

    1. Hyldgaard, C. et al "An unusual presentation of sarcoidosis with tetraplegia and severe osteolytic bone lesions." European Respiratory Journal 37.4 (2011): 964-966. Web. 19 Jan. 2022.

I

  1. Ikeda, D.

    1. Koiwa, H. et al "An autopsy case of pulmonary veno-occlusive disease refractory to imatinib." European Respiratory Journal 37.4 (2011): 968-970. Web. 19 Jan. 2022.

  2. Irving, L.B.

    1. Steinfort, D.P. et al "Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis." European Respiratory Journal 37.4 (2011): 902-910. Web. 19 Jan. 2022.

J

  1. Jabar, A.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

  2. Jaïs, X.

    1. Humbert, M. et al "From the authors:." European Respiratory Journal 37.4 (2011): 972-973. Web. 19 Jan. 2022.

  3. Jensen, R.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

  4. Jiménez Castro, D.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

  5. Jochault, L.

    1. Thaon, I. et al "Influence of hay and animal feed exposure on respiratory status: a longitudinal study." European Respiratory Journal 37.4 (2011): 767-774. Web. 19 Jan. 2022.

  6. Jurado-Gámez, B.

    1. Jurado-Gámez, B. et al "Relationship of oxidative stress and endothelial dysfunction in sleep apnoea." European Respiratory Journal 37.4 (2011): 873-879. Web. 19 Jan. 2022.

K

  1. Kambouchner, M.

    1. Kambouchner, M. et al "Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas." European Respiratory Journal 37.4 (2011): 835-840. Web. 19 Jan. 2022.

  2. Kerrigan, S.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

  3. Khor, Y.H.

    1. Steinfort, D.P. et al "Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis." European Respiratory Journal 37.4 (2011): 902-910. Web. 19 Jan. 2022.

  4. Kim, C.K.

    1. Suh, D.I. et al "Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children." European Respiratory Journal 37.4 (2011): 800-805. Web. 19 Jan. 2022.

  5. Koh, Y.Y.

    1. Suh, D.I. et al "Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children." European Respiratory Journal 37.4 (2011): 800-805. Web. 19 Jan. 2022.

  6. Koiwa, H.

    1. Koiwa, H. et al "An autopsy case of pulmonary veno-occlusive disease refractory to imatinib." European Respiratory Journal 37.4 (2011): 968-970. Web. 19 Jan. 2022.

  7. Kolar, F.

    1. Rivolta, I. et al "Interstitial pressure and lung oedema in chronic hypoxia." European Respiratory Journal 37.4 (2011): 943-949. Web. 19 Jan. 2022.

  8. Komlosi, Z.I.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

  9. Kopecna, D.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

  10. Kraskauskas, D.

    1. Yasuo, M. et al "Hypoxia inducible factor-1α in human emphysema lung tissue." European Respiratory Journal 37.4 (2011): 775-783. Web. 19 Jan. 2022.

  11. Kuyvenhoven, J.V.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

L

  1. Lagrou, K.

    1. Sibille, A. et al "Three colleagues with sarcoidosis?." European Respiratory Journal 37.4 (2011): 962-964. Web. 19 Jan. 2022.

  2. Laplante, J.J.

    1. Thaon, I. et al "Influence of hay and animal feed exposure on respiratory status: a longitudinal study." European Respiratory Journal 37.4 (2011): 767-774. Web. 19 Jan. 2022.

  3. Lee, J.K.

    1. Suh, D.I. et al "Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children." European Respiratory Journal 37.4 (2011): 800-805. Web. 19 Jan. 2022.

  4. Lefebvre, A.

    1. Thaon, I. et al "Influence of hay and animal feed exposure on respiratory status: a longitudinal study." European Respiratory Journal 37.4 (2011): 767-774. Web. 19 Jan. 2022.

  5. Lévy, P.

    1. McNicholas, W.T., and P. Lévy. "Portable monitoring in sleep apnoea: the way forward?." European Respiratory Journal 37.4 (2011): 749-751. Web. 19 Jan. 2022.

  6. Li, F.

    1. Li, F. et al "Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids." European Respiratory Journal 37.4 (2011): 933-942. Web. 19 Jan. 2022.

  7. Lopez-Barea, J.

    1. Jurado-Gámez, B. et al "Relationship of oxidative stress and endothelial dysfunction in sleep apnoea." European Respiratory Journal 37.4 (2011): 873-879. Web. 19 Jan. 2022.

  8. Lopez-Miranda, J.

    1. Jurado-Gámez, B. et al "Relationship of oxidative stress and endothelial dysfunction in sleep apnoea." European Respiratory Journal 37.4 (2011): 873-879. Web. 19 Jan. 2022.

  9. López-Sánchez, A.

    1. Sáenz, A. et al "Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation." European Respiratory Journal 37.4 (2011): 925-932. Web. 19 Jan. 2022.

  10. Losonczy, G.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

  11. Lou, W.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

  12. Løvgreen, M.

    1. Hyldgaard, C. et al "An unusual presentation of sarcoidosis with tetraplegia and severe osteolytic bone lesions." European Respiratory Journal 37.4 (2011): 964-966. Web. 19 Jan. 2022.

  13. Lucattelli, M.

    1. De Cunto, G. et al "Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2." European Respiratory Journal 37.4 (2011): 823-834. Web. 19 Jan. 2022.

  14. Lucchini, V.

    1. Rivolta, I. et al "Interstitial pressure and lung oedema in chronic hypoxia." European Respiratory Journal 37.4 (2011): 943-949. Web. 19 Jan. 2022.

  15. Luijks, M.

    1. Gielis, J. et al "Nodular pulmonary ossifications in differential diagnosis of solitary pulmonary nodules." European Respiratory Journal 37.4 (2011): 966-968. Web. 19 Jan. 2022.

  16. Lukácsovits, J.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

  17. Lungarella, G.

    1. De Cunto, G. et al "Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2." European Respiratory Journal 37.4 (2011): 823-834. Web. 19 Jan. 2022.

M

  1. Magrì, D.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  2. Make, B.

    1. Puhan, M.A. et al "The minimal important difference of exercise tests in severe COPD." European Respiratory Journal 37.4 (2011): 784-790. Web. 19 Jan. 2022.

  3. Manser, R.L.

    1. Steinfort, D.P. et al "Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis." European Respiratory Journal 37.4 (2011): 902-910. Web. 19 Jan. 2022.

  4. Marenzi, G.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  5. Masa, J.F.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  6. Máthé, C.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

  7. McNally, P.

    1. Finn, D., and P. McNally. "Estimated population prevalence of obstructive sleep apnoea in a community of German third graders." European Respiratory Journal 37.4 (2011): 975. Web. 19 Jan. 2022.

  8. McNicholas, W.T.

    1. McNicholas, W.T., and P. Lévy. "Portable monitoring in sleep apnoea: the way forward?." European Respiratory Journal 37.4 (2011): 749-751. Web. 19 Jan. 2022.

  9. Menzies, D.

    1. Oxlade, O., and D. Menzies. "From the authors:." European Respiratory Journal 37.4 (2011): 974-975. Web. 19 Jan. 2022.

  10. Migliori, G.B.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

  11. Miserocchi, G.

    1. Rivolta, I. et al "Interstitial pressure and lung oedema in chronic hypoxia." European Respiratory Journal 37.4 (2011): 943-949. Web. 19 Jan. 2022.

  12. Mizuno, S.

    1. Yasuo, M. et al "Hypoxia inducible factor-1α in human emphysema lung tissue." European Respiratory Journal 37.4 (2011): 775-783. Web. 19 Jan. 2022.

  13. Mogoanta, L.

    1. Kambouchner, M. et al "Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas." European Respiratory Journal 37.4 (2011): 835-840. Web. 19 Jan. 2022.

  14. Mohapatra, P.R.

    1. Mohapatra, P.R., and D.T. Hari. "Predicting outcomes and drug resistance with new standardised treatment." European Respiratory Journal 37.4 (2011): 974. Web. 19 Jan. 2022.

  15. Montani, D.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.
    2. Humbert, M. et al "From the authors:." European Respiratory Journal 37.4 (2011): 972-973. Web. 19 Jan. 2022.

  16. Moores, L.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

  17. Mosenifar, Z.

    1. Puhan, M.A. et al "The minimal important difference of exercise tests in severe COPD." European Respiratory Journal 37.4 (2011): 784-790. Web. 19 Jan. 2022.

  18. Mota, M.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  19. Müller, V.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

  20. Muñoz-Cabrera, L.

    1. Jurado-Gámez, B. et al "Relationship of oxidative stress and endothelial dysfunction in sleep apnoea." European Respiratory Journal 37.4 (2011): 873-879. Web. 19 Jan. 2022.

N

  1. Natarajan, R.

    1. Yasuo, M. et al "Hypoxia inducible factor-1α in human emphysema lung tissue." European Respiratory Journal 37.4 (2011): 775-783. Web. 19 Jan. 2022.

  2. Nemery, B.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

  3. Nishimura, M.

    1. Koiwa, H. et al "An autopsy case of pulmonary veno-occlusive disease refractory to imatinib." European Respiratory Journal 37.4 (2011): 968-970. Web. 19 Jan. 2022.

  4. Nordestgaard, B.G.

    1. Bækvad-Hansen, M., B.G. Nordestgaard, and M. Dahl. "Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals." European Respiratory Journal 37.4 (2011): 791-799. Web. 19 Jan. 2022.

  5. Nortier, J.

    1. Nortier, J., and J-P. Sculier. "Thoracic malignancies, cisplatin and renal function." European Respiratory Journal 37.4 (2011): 760-761. Web. 19 Jan. 2022.

O

  1. O'Callaghan, D.S.

    1. Humbert, M. et al "From the authors:." European Respiratory Journal 37.4 (2011): 972-973. Web. 19 Jan. 2022.

  2. Ohira, H.

    1. Koiwa, H. et al "An autopsy case of pulmonary veno-occlusive disease refractory to imatinib." European Respiratory Journal 37.4 (2011): 968-970. Web. 19 Jan. 2022.

  3. Opitz, C.F.

    1. Wensel, R. et al "Prognosis in pulmonary arterial hypertension." European Respiratory Journal 37.4 (2011): 971-972. Web. 19 Jan. 2022.

  4. Oxlade, O.

    1. Oxlade, O., and D. Menzies. "From the authors:." European Respiratory Journal 37.4 (2011): 974-975. Web. 19 Jan. 2022.

P

  1. Palazzo, F.

    1. Rivolta, I. et al "Interstitial pressure and lung oedema in chronic hypoxia." European Respiratory Journal 37.4 (2011): 943-949. Web. 19 Jan. 2022.

  2. Peinado, V.I.

    1. Barberà, J.A., and V.I. Peinado. "Disruption of the lung structure maintenance programme: a comprehensive view of emphysema development." European Respiratory Journal 37.4 (2011): 752-754. Web. 19 Jan. 2022.

  3. Pereira, R.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  4. Perez-Jimenez, F.

    1. Jurado-Gámez, B. et al "Relationship of oxidative stress and endothelial dysfunction in sleep apnoea." European Respiratory Journal 37.4 (2011): 873-879. Web. 19 Jan. 2022.

  5. Perros, F.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  6. Pham, T.M.T.

    1. Pham, T.M.T. et al "Regional ventilation distribution in the first 6 months of life." European Respiratory Journal 37.4 (2011): 919-924. Web. 19 Jan. 2022.

  7. Pialoux, V.

    1. Brugniaux, J.V. et al "Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans." European Respiratory Journal 37.4 (2011): 880-887. Web. 19 Jan. 2022.

  8. Pirici, D.

    1. Kambouchner, M. et al "Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas." European Respiratory Journal 37.4 (2011): 835-840. Web. 19 Jan. 2022.

  9. Poets, C.F.

    1. Urschitz, M.S. et al "From the authors:." European Respiratory Journal 37.4 (2011): 975-976. Web. 19 Jan. 2022.

  10. Postmus, P.E.

    1. Boerrigter, B.G. et al "Cardiac shunt in COPD as a cause of severe hypoxaemia: probably not so uncommon after all." European Respiratory Journal 37.4 (2011): 960-962. Web. 19 Jan. 2022.

  11. Poulin, M.J.

    1. Brugniaux, J.V. et al "Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans." European Respiratory Journal 37.4 (2011): 880-887. Web. 19 Jan. 2022.

  12. Price, L.C.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  13. Puhan, M.A.

    1. Puhan, M.A. et al "The minimal important difference of exercise tests in severe COPD." European Respiratory Journal 37.4 (2011): 784-790. Web. 19 Jan. 2022.

R

  1. Rabe, K.F.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

  2. Raghu, G.

    1. Raghu, G.. "Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011." European Respiratory Journal 37.4 (2011): 743-746. Web. 19 Jan. 2022.

  3. Rahman, N.M.

    1. Slade, M.G. et al "Improving standards in flexible bronchoscopy for lung cancer." European Respiratory Journal 37.4 (2011): 895-901. Web. 19 Jan. 2022.

  4. Ratjen, F.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

  5. Raviglione, M.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

  6. Rieder, H.L.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

  7. Ries, A.

    1. Puhan, M.A. et al "The minimal important difference of exercise tests in severe COPD." European Respiratory Journal 37.4 (2011): 784-790. Web. 19 Jan. 2022.

  8. Riesco, J.A.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  9. Rivolta, I.

    1. Rivolta, I. et al "Interstitial pressure and lung oedema in chronic hypoxia." European Respiratory Journal 37.4 (2011): 943-949. Web. 19 Jan. 2022.

  10. Rocchetti, M.

    1. Rivolta, I. et al "Interstitial pressure and lung oedema in chronic hypoxia." European Respiratory Journal 37.4 (2011): 943-949. Web. 19 Jan. 2022.

  11. Roussos, C.

    1. Decramer, M., C. Roussos, and J. Hogg. "In memoriam Prof. Peter T. Macklem, 1931–2011: a tribute from the European Respiratory Society." European Respiratory Journal 37.4 (2011): 735-737. Web. 19 Jan. 2022.

  12. Rubio, M.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

S

  1. Sáenz, A.

    1. Sáenz, A. et al "Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation." European Respiratory Journal 37.4 (2011): 925-932. Web. 19 Jan. 2022.

  2. Salgado, R.

    1. Gielis, J. et al "Nodular pulmonary ossifications in differential diagnosis of solitary pulmonary nodules." European Respiratory Journal 37.4 (2011): 966-968. Web. 19 Jan. 2022.

  3. Sam, A.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

  4. Sánchez, D.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

  5. Santos, M.

    1. Sáenz, A. et al "Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation." European Respiratory Journal 37.4 (2011): 925-932. Web. 19 Jan. 2022.

  6. Schibler, A.

    1. Pham, T.M.T. et al "Regional ventilation distribution in the first 6 months of life." European Respiratory Journal 37.4 (2011): 919-924. Web. 19 Jan. 2022.

  7. Schlaud, M.

    1. Urschitz, M.S. et al "From the authors:." European Respiratory Journal 37.4 (2011): 975-976. Web. 19 Jan. 2022.

  8. Schwoebel, V.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

  9. Sciomer, S.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  10. Sciurba, F.

    1. Puhan, M.A. et al "The minimal important difference of exercise tests in severe COPD." European Respiratory Journal 37.4 (2011): 784-790. Web. 19 Jan. 2022.

  11. Sculier, J-P.

    1. Nortier, J., and J-P. Sculier. "Thoracic malignancies, cisplatin and renal function." European Respiratory Journal 37.4 (2011): 760-761. Web. 19 Jan. 2022.

  12. Segal, R.

    1. Sáenz, A. et al "Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation." European Respiratory Journal 37.4 (2011): 925-932. Web. 19 Jan. 2022.

  13. Shao, D.M.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  14. Sibille, A.

    1. Sibille, A. et al "Three colleagues with sarcoidosis?." European Respiratory Journal 37.4 (2011): 962-964. Web. 19 Jan. 2022.

  15. Sibille, Y.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

  16. Simonds, A.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

  17. Simonneau, G.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.
    2. Humbert, M. et al "From the authors:." European Respiratory Journal 37.4 (2011): 972-973. Web. 19 Jan. 2022.

  18. Sisillo, E.

    1. Agostoni, P. et al "Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study." European Respiratory Journal 37.4 (2011): 841-847. Web. 19 Jan. 2022.

  19. Sitbon, O.

    1. Humbert, M. et al "From the authors:." European Respiratory Journal 37.4 (2011): 972-973. Web. 19 Jan. 2022.

  20. Slade, G.C.

    1. Slade, M.G. et al "Improving standards in flexible bronchoscopy for lung cancer." European Respiratory Journal 37.4 (2011): 895-901. Web. 19 Jan. 2022.

  21. Slade, M.G.

    1. Slade, M.G. et al "Improving standards in flexible bronchoscopy for lung cancer." European Respiratory Journal 37.4 (2011): 895-901. Web. 19 Jan. 2022.

  22. Smith, N.L.

    1. Smith, N.L., and D.W. Denning. "Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma." European Respiratory Journal 37.4 (2011): 865-872. Web. 19 Jan. 2022.

  23. Souza, R.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.
    2. Humbert, M. et al "From the authors:." European Respiratory Journal 37.4 (2011): 972-973. Web. 19 Jan. 2022.

  24. Stanton, A.E.

    1. Slade, M.G. et al "Improving standards in flexible bronchoscopy for lung cancer." European Respiratory Journal 37.4 (2011): 895-901. Web. 19 Jan. 2022.

  25. Steinfort, D.P.

    1. Steinfort, D.P. et al "Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis." European Respiratory Journal 37.4 (2011): 902-910. Web. 19 Jan. 2022.

  26. Stocks, J.

    1. Hall, G.L., and J. Stocks. "Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash?." European Respiratory Journal 37.4 (2011): 757-759. Web. 19 Jan. 2022.

  27. Subbarao, P.

    1. Amin, R. et al "The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis." European Respiratory Journal 37.4 (2011): 806-812. Web. 19 Jan. 2022.

  28. Suh, D.I.

    1. Suh, D.I. et al "Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children." European Respiratory Journal 37.4 (2011): 800-805. Web. 19 Jan. 2022.

  29. Szondy, K.

    1. Máthé, C. et al "Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients." European Respiratory Journal 37.4 (2011): 888-894. Web. 19 Jan. 2022.

T

  1. Tanino, M.

    1. Koiwa, H. et al "An autopsy case of pulmonary veno-occlusive disease refractory to imatinib." European Respiratory Journal 37.4 (2011): 968-970. Web. 19 Jan. 2022.

  2. Tcherakian, C.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  3. Teran, J.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  4. Thaon, I.

    1. Thaon, I. et al "Influence of hay and animal feed exposure on respiratory status: a longitudinal study." European Respiratory Journal 37.4 (2011): 767-774. Web. 19 Jan. 2022.

  5. Thiebaut, A.

    1. Thaon, I. et al "Influence of hay and animal feed exposure on respiratory status: a longitudinal study." European Respiratory Journal 37.4 (2011): 767-774. Web. 19 Jan. 2022.

  6. Torfs, M.

    1. Gielis, J. et al "Nodular pulmonary ossifications in differential diagnosis of solitary pulmonary nodules." European Respiratory Journal 37.4 (2011): 966-968. Web. 19 Jan. 2022.

  7. Triantaphyllopoulos, K.

    1. Li, F. et al "Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids." European Respiratory Journal 37.4 (2011): 933-942. Web. 19 Jan. 2022.

  8. Troosters, T.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.
    2. Troosters, T.. "How important is a minimal difference?." European Respiratory Journal 37.4 (2011): 755-756. Web. 19 Jan. 2022.

  9. Tsujino, I.

    1. Koiwa, H. et al "An autopsy case of pulmonary veno-occlusive disease refractory to imatinib." European Respiratory Journal 37.4 (2011): 968-970. Web. 19 Jan. 2022.

  10. Turnbull, A.

    1. Decramer, M. et al "The European Union conference on chronic respiratory disease: purpose and conclusions." European Respiratory Journal 37.4 (2011): 738-742. Web. 19 Jan. 2022.

U

  1. Uhl, J-F.

    1. Kambouchner, M. et al "Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas." European Respiratory Journal 37.4 (2011): 835-840. Web. 19 Jan. 2022.

  2. Urschitz, M.S.

    1. Urschitz, M.S. et al "From the authors:." European Respiratory Journal 37.4 (2011): 975-976. Web. 19 Jan. 2022.

V

  1. Valeyre, D.

    1. Kambouchner, M. et al "Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas." European Respiratory Journal 37.4 (2011): 835-840. Web. 19 Jan. 2022.

  2. Van Bleyenbergh, P.

    1. Sibille, A. et al "Three colleagues with sarcoidosis?." European Respiratory Journal 37.4 (2011): 962-964. Web. 19 Jan. 2022.

  3. van der Poll, T.

    1. Wieland, C.W. et al "Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2." European Respiratory Journal 37.4 (2011): 848-857. Web. 19 Jan. 2022.

  4. van Lieshout, M.H.P.

    1. Wieland, C.W. et al "Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2." European Respiratory Journal 37.4 (2011): 848-857. Web. 19 Jan. 2022.

  5. Van Schil, P.E.

    1. Gielis, J. et al "Nodular pulmonary ossifications in differential diagnosis of solitary pulmonary nodules." European Respiratory Journal 37.4 (2011): 966-968. Web. 19 Jan. 2022.

  6. Varela, A.

    1. Sáenz, A. et al "Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation." European Respiratory Journal 37.4 (2011): 925-932. Web. 19 Jan. 2022.

  7. Veen, J.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

  8. Verstraeten, A.

    1. Sibille, A. et al "Three colleagues with sarcoidosis?." European Respiratory Journal 37.4 (2011): 962-964. Web. 19 Jan. 2022.

  9. Voelkel, N.F.

    1. Yasuo, M. et al "Hypoxia inducible factor-1α in human emphysema lung tissue." European Respiratory Journal 37.4 (2011): 775-783. Web. 19 Jan. 2022.

  10. Vonk-Noordegraaf, A.

    1. Boerrigter, B.G. et al "Cardiac shunt in COPD as a cause of severe hypoxaemia: probably not so uncommon after all." European Respiratory Journal 37.4 (2011): 960-962. Web. 19 Jan. 2022.

W

  1. Wagner, C.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

  2. Wensel, R.

    1. Wensel, R. et al "Prognosis in pulmonary arterial hypertension." European Respiratory Journal 37.4 (2011): 971-972. Web. 19 Jan. 2022.

  3. Westerhof, N.

    1. Boerrigter, B.G. et al "Cardiac shunt in COPD as a cause of severe hypoxaemia: probably not so uncommon after all." European Respiratory Journal 37.4 (2011): 960-962. Web. 19 Jan. 2022.

  4. Wieland, C.W.

    1. Wieland, C.W. et al "Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2." European Respiratory Journal 37.4 (2011): 848-857. Web. 19 Jan. 2022.

  5. Wise, R.A.

    1. Puhan, M.A. et al "The minimal important difference of exercise tests in severe COPD." European Respiratory Journal 37.4 (2011): 784-790. Web. 19 Jan. 2022.

  6. Wort, S.J.

    1. Price, L.C. et al "Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats." European Respiratory Journal 37.4 (2011): 813-822. Web. 19 Jan. 2022.

  7. Wuyts, W.

    1. Sibille, A. et al "Three colleagues with sarcoidosis?." European Respiratory Journal 37.4 (2011): 962-964. Web. 19 Jan. 2022.

Y

  1. Yaïci, A.

    1. Humbert, M. et al "From the authors:." European Respiratory Journal 37.4 (2011): 972-973. Web. 19 Jan. 2022.

  2. Yasuo, M.

    1. Yasuo, M. et al "Hypoxia inducible factor-1α in human emphysema lung tissue." European Respiratory Journal 37.4 (2011): 775-783. Web. 19 Jan. 2022.

  3. Yuill, M.

    1. Pham, T.M.T. et al "Regional ventilation distribution in the first 6 months of life." European Respiratory Journal 37.4 (2011): 919-924. Web. 19 Jan. 2022.

  4. Yusen, R.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

Z

  1. Zaleskis, R.

    1. Veen, J. et al "Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops." European Respiratory Journal 37.4 (2011): 950-959. Web. 19 Jan. 2022.

  2. Zamarro, C.

    1. Sam, A. et al "The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism." European Respiratory Journal 37.4 (2011): 762-766. Web. 19 Jan. 2022.

  3. Zamora, M.

    1. Yasuo, M. et al "Hypoxia inducible factor-1α in human emphysema lung tissue." European Respiratory Journal 37.4 (2011): 775-783. Web. 19 Jan. 2022.

  4. Zamorano, J.

    1. Masa, J.F. et al "Validity of spirometry performed online." European Respiratory Journal 37.4 (2011): 911-918. Web. 19 Jan. 2022.

  5. Zaza, A.

    1. Rivolta, I. et al "Interstitial pressure and lung oedema in chronic hypoxia." European Respiratory Journal 37.4 (2011): 943-949. Web. 19 Jan. 2022.

  6. Zhang, M.

    1. Li, F. et al "Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids." European Respiratory Journal 37.4 (2011): 933-942. Web. 19 Jan. 2022.

  7. Zhou, X.

    1. Li, F. et al "Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids." European Respiratory Journal 37.4 (2011): 933-942. Web. 19 Jan. 2022.
Back to top
European Respiratory Journal: 37 (4)

Search Within This Issue

Jump to

Manage Table of content Alerts